StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30127% above fair value
$42.62+0.05 (+0.12%)

Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –

Teva Pharmaceutical Industries TAPI Disposal Group — Inventories Held for Sale by Quarter

TAPI Disposal Group — Inventories Held for Sale ($M)

Teva Pharmaceutical Industries TAPI Disposal Group — Inventories Held for Sale: $560M in Q3 2026, up 9.4% from a year earlier.

Latest, Q3 2026
560
Period ended Sep 30, 2026
Change on a year earlier
+9.4%
512 in Q3 2025
History
27 quarters
Since Q4 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 10-Q (0000818686-26-000006) ↗

Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTAPI Disposal Group — Inventories Held for Sale ($M)Year on yearSource
Q3 2026Sep 30, 2026560+9.4%SEC Form 10-Q (0000818686-26-000006) ↗
Q2 2026Jun 30, 2026534+2.7%SEC Form 10-Q (0001193125-26-323619) ↗
Q1 2026Mar 31, 2026527+5.0%SEC Form 10-Q (0001193125-26-191513) ↗
Q4 2025Dec 31, 2025506-21.8%SEC Form 10-Q (0000818686-26-000006) ↗
Q3 2025Sep 30, 2025512+203.0%SEC Form 10-Q (0001193125-25-266895) ↗
Q2 2025Jun 30, 2025520+227.0%SEC Form 10-Q (0001193125-25-169296) ↗
Q1 2025Mar 31, 2025502+197.0%SEC Form 10-Q (0001193125-25-114889) ↗
Q4 2024Dec 31, 2024647+5,291.7%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2024Sep 30, 2024169+2,314.3%SEC Form 10-Q (0001193125-24-252039) ↗
Q2 2024Jun 30, 2024159+1,666.7%SEC Form 10-Q (0001193125-24-189924) ↗
Q1 2024Mar 31, 2024169+8,350.0%SEC Form 10-Q (0001193125-24-134200) ↗
Q4 2023Dec 31, 202312+500.0%SEC Form 10-K (0001193125-25-020826) ↗
Q3 2023Sep 30, 20237–SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2023Jun 30, 20239–SEC Form 10-Q (0001193125-23-201707) ↗
Q1 2023Mar 31, 20232–SEC Form 10-Q (0001193125-23-140697) ↗
Q4 2022Dec 31, 202220.0%SEC Form 10-K (0001193125-24-031005) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries TAPI Disposal Group — Inventories Held for Sale ($M), quarterly Q4 2019–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-tapi-hfs-inv

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?